 InSurE. P<0.01RR=0.56, CI,
INTRODUCTION
Neonatal respiratory distress syndrome in premature newborns is the most common cause of morbidity.
CPAP before surfactant administration. If for establishing spo2 >85% we needed fio2>30%, surfactant was administered and CPAP was continued unless pco2>50-60mmhg and ph<7.2 then ventilation was continued with ventilator. Surfactant was administered based on two separate protocols, InSurE or TEC accordance to 2010 European Consensus.
Written parenteral permission was obtained, before including neonates in this study.
.
Study groups
This study was conducted from February 2010 and October 2012.We enrolled 136 neonates with gestational ages between 27-32 weeks whom were eligible for inclusion as mentioned above. They were randomized to two different groups of surfactant administration, (TEC and InSurE).
Neonates with Apgar score min 5 less than 6, congenital malformations and congenital heart disease were excluded from this study.
TEC Procedure
NCPAP pressure was increased as much as 8 to 10 cm H20 before the procedure was started.
In order to decrease secretions of the neonate, we administered Atropin 5ug/kg before intubation. A 5f feeding tube was guided through 1 to 2 cm below the vocal cords.
After placement the Feeding tube, laryngoscope was removed from the mouth and surfactant was administrated slowly over 1 to 3 minutes (16 
RESULTS
In this multi center study, 136 neonates with gestational ages between 27-32 weeks were enrolled in three university hospitals of Tabriz, Isfahan and Mashhad. They were randomized into two groups of TEC and InSurE.66 infants received surfactant via Tec procedure and 70 infants were treated via InSurE method.
Demographic information in infants receiving TEC are compared with method infants (Table 1) . Infants in TEC group received surfactant within median time of 3.9 hrs and infants in InSurE group were treated at a median time of 4.5 hrs. TEC procedure was performed by three consultant neonatologists and four neonatal fellows.
Desaturation during InSurE method was more than TEC that was statistically significant p<0.00 (Table   2 ).There was no difference between second dose surfactant requirement between two procedures. Po2 increased after surfactant administration in both groups. Pco2 decreased in both groups 2 hrs after surfactant administration but the slope of this decrease was more steep in InsurE p<0.08. Hco3 increased 2 hrs after surfactant administration in TEC group that was statistically significant p<0.05.PH increased in both groups 2 hrs after surfactant administration but there was no difference statistically. A rapid decrease in CPAP pressure was noted in InsurE after 2hrs but in TEC was shown after 24 hrs (Figure 1 ). Fio2 requirement decreased rapidly after 15 minutes in TEC but this decrease was shown after1hr in method ( Figure   2 ). Spo2 raised rapidly in both groups after 15 minutes.
Heart rate rose to more than 150 bpm in InSurE group after 2 hrs, but it decreased in TEC group after 1hr to less than 145 bpm. Mortality reduced significantly in TEC group p<0.01, RR=0.56,CI 95%(0.42-0.76).There was no difference in Prevalence of BPD between two groups. There was not any difference in other neonatal out comes between two groups of TEC and InSurE (Table 3) . ration increased in InSurE which may lead to back ground complications due to ischemia as NEC that increased in control. In our study and Dargavilles study there were no difference in surfactant re administration (18) . BPD decreased significantly in Kribs and Kanmazstudy (17, 19) in TEC but there were no difference in our and Dargavilles study between two groups (18) .
This may be due to high prevalence of sepsis in our wards due to over admission of infants in our NICUs and increase in ratio of patient to nurse (10 to 1).
Requirement for PDA treatment increased in our study and Dargavilles and as he argues may be due to lung improvement and increased left to right shunt (18) . 
